echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Nutrition News > Study reveals high-risk subtype of relapsing childhood AML

    Study reveals high-risk subtype of relapsing childhood AML

    • Last Update: 2022-04-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Image: St.


    Source: St.


    When acute myeloid leukemia (AML) relapses, treatment is more difficult, with dismal results


     

    "We started out wide because, obviously, we didn't have a good enough understanding of what causes childhood acute myeloid leukemia to relapse in the first place," said co-corresponding author Jeffery Klco, MD, of the St.


     

    "It became clear very early on that there was a group of cases with strange alterations in this gene UBTF that had really only been considered superficially in the past," Klco said


     

    A new high-risk subtype

    The researchers assessed the genomics of 136 St.


     

    UBTF-TD AML is more common in children than adults


     

    genetic analysis

    The genomics of AML has been studied for many years, but this mutation has been mostly overlooked or undetected in previous work


     

    "This is an extremely difficult mutation to detect, so it took a lot of work to develop the correct algorithm


     

    "Now that we know what we're looking for and how to find it, we can easily apply it to clinical genomics," Ma said


     

    Clinical genomics can be used to screen for UBTF-TD mutations in AML to help identify high-risk patients


     


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.